Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Location: United Kingdom, England, Nottingham
Employees: 1001-5000
Phone: +44 115 974 9000
Founded date: 1990
Investors 1
| Date | Name | Website |
| - | GHO Capita... | ghocapital... |
Mentions in press and media 9
| Date | Title | Description |
| 05.01.2023 | Navigating the Small Molecule CMC Pathway: Strategies for Avoiding Regulatory Hurdles and Early Drug Development Pitfalls, Upcoming Webinar Hosted by Xtalks | With the stakes high, having trusted and experienced guidance at this stage can help streamline the pathway from discovery towards IND and beyond, reduce risk and improve the likelihood of both clinical and commercial success. TORONTO (PRWE... |
| 29.08.2022 | Non-Clinical vs Clinical: Risks & Considerations When Developing Modified Release Dosage Forms, Upcoming Webinar Hosted by Xtalks | Human gastrointestinal anatomy and physiology strongly influences drug release and performance of modified release dosage forms given regional variations in pH, fluid volumes and compositions, surface area, metabolizing enzymes and membrane... |
| 26.05.2022 | Moving Drug Substance Off the Critical Path — Streamlined Strategies to Accelerate to First-in-Human & Beyond, Upcoming Webinar Hosted by Xtalks | Drug substance plays a major part in ensuring a drug program achieves its major milestones, keeps to budget and delivers on its corporate goals. TORONTO (PRWEB) May 26, 2022 The need for accelerated drug development has become even greater,... |
| 11.05.2022 | Overcoming Complex Formulation Challenges: Integrated Strategies for Poor Solubility, Modified Release & Pediatrics, Upcoming Webinar Hosted by Xtalks | With the ultimate goal being to get treatments to patients faster, drug developers can leverage an integrated approach to rapidly screen formulation technologies and dosage forms in as early as the preclinical stage. TORONTO (PRWEB) May 11,... |
| 11.02.2021 | Quotient, buoyed by Covid-19 work, buys Arcinova in effort to build end-to-end CDMO brand | Flush with cash from Covid-19 work, contract manufacturers are having their own M&A mini-boom. Now, a UK-based manufacturing services firm is snagging another company headquarter on the Isles, looking to set up an en... |
| 19.07.2019 | Quotient Sciences Receives Majority Investment from Permira | Quotient Sciences, a Nottingham, England, UK-based provider of formulation development, clinical pharmacology, clinical & commercial manufacturing services to the pharmaceutical & biotech industry, received a majority stake investme... |
| 11.12.2017 | Onespacemedia launches website to support complex rebrand of Quotient Sciences | Onespacemedia launches website to support complex rebrand of Quotient Sciences 11-12-2017 Onespacemedia has launched a new website for Quotient Sciences, to support a complex rebrand of the company. Quotient Sciences is a globally establish... |
| 11.12.2017 | Onespacemedia launches website to support complex rebrand of Quotient Sciences | Onespacemedia has launched a new website for Quotient Sciences, to support a complex rebrand of the company. Quotient Sciences is a globally established drug development services organisation with almost 30 years of experience. The company ... |
| - | BGF exits Alnwick-headquartered Arcinova | BGF has announced the exit of its investment in Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). Following a period of growth and expansion, the business has been acquired by Quotient Science... |